Total Payments
$3,365
2024 Payments
$431.01
Companies
24
Transactions
226
Medicare Patients
3,596
Medicare Billing
$207,156
Payment Breakdown by Category
Food & Beverage$3,354 (99.7%)
Education$10.87 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,354 | 225 | 99.7% |
| Education | $10.87 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,142 | 91 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $376.56 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $307.02 | 20 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $273.98 | 19 | $0 (2024) |
| Amgen Inc. | $218.32 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $187.37 | 13 | $0 (2024) |
| Lundbeck LLC | $115.56 | 8 | $0 (2021) |
| PFIZER INC. | $111.89 | 6 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $98.24 | 6 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $97.72 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $431.01 | 23 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($98.24) |
| 2023 | $596.74 | 37 | Novartis Pharmaceuticals Corporation ($168.61) |
| 2022 | $725.73 | 51 | Novartis Pharmaceuticals Corporation ($276.92) |
| 2021 | $616.47 | 44 | Novartis Pharmaceuticals Corporation ($171.88) |
| 2020 | $220.47 | 14 | Novartis Pharmaceuticals Corporation ($110.39) |
| 2019 | $154.28 | 11 | Novartis Pharmaceuticals Corporation ($76.98) |
| 2018 | $256.48 | 15 | iRhythm Technologies, Inc. ($70.95) |
| 2017 | $363.41 | 31 | Novartis Pharmaceuticals Corporation ($191.62) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.11 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.42 | General |
| 06/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Cardiology | ||||||
| 05/15/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 05/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiology | ||||||
| 05/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Cardiovascular | ||||||
| 04/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: Cardiovascular | ||||||
| 02/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: DIABETES | ||||||
| 11/21/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.38 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 696 | 856 | $100,118 | $40,440 |
| 2022 | 14 | 1,089 | 1,362 | $153,242 | $59,862 |
| 2021 | 13 | 947 | 1,305 | $112,882 | $56,411 |
| 2020 | 12 | 864 | 1,121 | $109,450 | $50,443 |
Total Patients
3,596
Total Services
4,644
Medicare Billing
$207,156
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 82 | 142 | $30,734 | $12,999 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 133 | $18,630 | $10,278 | 55.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 61 | $25,732 | $7,856 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 52 | $5,720 | $2,541 | 44.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 22 | 35 | $3,675 | $1,639 | 44.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 26 | $3,899 | $1,584 | 40.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 221 | 251 | $6,275 | $1,544 | 24.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 70 | 71 | $2,933 | $1,128 | 38.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 69 | 70 | $2,145 | $736.92 | 34.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $375.00 | $135.41 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 248 | $34,720 | $21,819 | 62.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 41 | 97 | $20,995 | $7,321 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 101 | $11,110 | $5,804 | 52.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 92 | 93 | $36,270 | $4,723 | 13.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $13,077 | $4,566 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $6,880 | $3,857 | 56.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 165 | 168 | $6,720 | $2,746 | 40.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 27 | $5,295 | $2,499 | 47.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 165 | 168 | $5,040 | $1,830 | 36.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 217 | 246 | $6,150 | $1,475 | 24.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 18 | 26 | $2,730 | $1,054 | 38.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 14 | 55 | $1,650 | $927.35 | 56.2% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2022 | 15 | 19 | $1,330 | $797.40 | 60.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 46 | 51 | $1,275 | $442.69 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 280 | $39,200 | $24,835 | 63.4% |
About Dr. Ellen Kehoe, DO
Dr. Ellen Kehoe, DO is a Cardiovascular Disease healthcare provider based in Mt Pleasant, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619975513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ellen Kehoe, DO has received a total of $3,365 in payments from pharmaceutical and medical device companies, with $431.01 received in 2024. These payments were reported across 226 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,354).
As a Medicare-enrolled provider, Kehoe has provided services to 3,596 Medicare beneficiaries, totaling 4,644 services with total Medicare billing of $207,156. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Mt Pleasant, MI
- Active Since 07/13/2005
- Last Updated 09/04/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1619975513
Products in Payments
- ENTRESTO (Drug) $741.86
- LEQVIO (Drug) $400.11
- JARDIANCE (Drug) $335.22
- VERQUVO (Drug) $307.02
- ELIQUIS (Drug) $215.56
- XARELTO (Drug) $174.59
- CAMZYOS (Drug) $144.56
- Repatha (Biological) $123.08
- NORTHERA (Drug) $115.56
- LifeVest (Device) $98.24
- OPSUMIT (Drug) $97.72
- Corlanor (Drug) $95.24
- ZIO Patch (Device) $86.23
- BRILINTA (Drug) $82.06
- MULTAQ (Drug) $52.00
- PRADAXA (Drug) $41.34
- NEXLETOL (Drug) $36.91
- Vascepa (Drug) $31.60
- COBALT DR MRI SURESCAN (Device) $28.92
- VYNDAQEL (Drug) $25.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.